{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:14:36Z","timestamp":1772248476088,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/s10156-007-0569-9","type":"journal-article","created":{"date-parts":[[2008,2,23]],"date-time":"2008-02-23T07:13:32Z","timestamp":1203750812000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin"],"prefix":"10.1016","volume":"14","author":[{"given":"Tomoko","family":"Oshiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Ikeda-Dantsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariaki","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenzo","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-007-0569-9_bib0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to VCM","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1007\/s10156-007-0569-9_bib0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199911183412117","article-title":"The effects of VCM and \u03b2-lactam antibiotics on vancomycin-resistant Staphylococcus aureus","volume":"341","author":"Haraga","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-007-0569-9_bib0015","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/AAC.44.2.272-277.2000","article-title":"Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates","volume":"44","author":"Boyle-Vavra","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/AAC.44.2.294-303.2000","article-title":"Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds","volume":"44","author":"Pfeltz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0030","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/JCM.41.4.1687-1693.2003","volume":"41","author":"Sieradzki","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-007-0569-9_bib0035","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(99)01017-X","article-title":"Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to VCM","volume":"353","author":"Ariza","year":"1999","journal-title":"Lancet"},{"key":"10.1007\/s10156-007-0569-9_bib0040","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","article-title":"Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections","volume":"16","author":"Moise","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1007\/s10156-007-0569-9_bib0045","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/AAC.47.4.1262-1266.2003","article-title":"Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylocococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis","volume":"47","author":"Moore","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/520429","article-title":"Bacteremia caused by staphylococci with inducible vancomycin heteroresistance","volume":"29","author":"Wong","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-007-0569-9_bib0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1201-9712(02)90165-7","article-title":"Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient-importance of low-level resistance to vancomycin","volume":"6","author":"Haraga","year":"2002","journal-title":"Int J Infect Dis"},{"key":"10.1007\/s10156-007-0569-9_bib0060","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/JCM.37.9.3068-3071.1999","article-title":"Interaction between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility","volume":"37","author":"Howe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-007-0569-9_bib0065","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/AAC.45.4.1292-1294.2001","article-title":"Combination effect of vancomycin and \u03b2-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin","volume":"45","author":"Aritaka","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2003.05.018","article-title":"Method of detecting \u03b2-lactam antibiotic induced vancomycin resistant MRSA (BIVR)","volume":"23","author":"Hanaki","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1007\/s10156-007-0569-9_bib0075","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/jb.172.11.6494-6498.1990","article-title":"Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis","volume":"172","author":"Sugai","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1007\/s10156-007-0569-9_bib0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1348-0421.1998.tb02276.x","article-title":"Zymographic characterization of Staphylococcus aureus cell wall","volume":"42","author":"Ohta","year":"1998","journal-title":"Microbiol Immunol"},{"key":"10.1007\/s10156-007-0569-9_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000239355","article-title":"Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime","volume":"41","author":"Nomura","year":"1995","journal-title":"Chemotherapy"},{"key":"10.1007\/s10156-007-0569-9_bib0090","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/AAC.43.7.1747","article-title":"Combinations of vancomycin and \u03b2-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin","volume":"43","author":"Climo","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199902183400704","article-title":"The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection","volume":"340","author":"Sieradzki","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-007-0569-9_bib0100","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/AAC.44.5.1394-1396.2000","article-title":"Vancomycin and oxacillin synergy for methicillin-resistant staphylococci","volume":"44","author":"Domaracki","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/AAC.6.4.411","article-title":"Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and resistant staphylococci","volume":"6","author":"Minuth","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0110","first-page":"847","article-title":"Effects of combinations of vancomycin with other antibiotics against methicillin-resistant Staphylococcus aureus","volume":"34","author":"Takahashi","year":"1986","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0115","first-page":"1","article-title":"Penetration of minocycline hydrochloride into lung tissue and sputum","volume":"47","author":"Watanabe","year":"2001","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jac\/5.4.475","article-title":"Vancomycin concentration in human tissues: preliminary report","volume":"5","author":"Torres","year":"1979","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0125","first-page":"123","article-title":"Vancomycin inhalation therapy \u2013 a pharmacokinetic and clinical study of vancomycin","volume":"122","author":"Niituma","year":"1996","journal-title":"Antibiot Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-007-0569-9_bib0135","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/AAC.48.10.3749-3757.2004","article-title":"Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus","volume":"48","author":"Koehl","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jac\/48.5.617","article-title":"Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate","volume":"48","author":"Boyle-Vavra","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0145","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/JB.185.24.7103-7110.2003","article-title":"Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus","volume":"185","author":"Sieradzki","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1007\/s10156-007-0569-9_bib0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-007-0569-9_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/42.2.199","article-title":"Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50","volume":"42","author":"Hanaki","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-007-0569-9_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X08707980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X08707980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-007-0569-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:46:14Z","timestamp":1761158774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X08707980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1341321X08707980"],"URL":"https:\/\/doi.org\/10.1007\/s10156-007-0569-9","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-007-0569-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}